Cargando…
Effectiveness and safety of dual therapy with rilpivirine and boosted darunavir in treatment-experienced patients with advanced HIV infection: a preliminary 24 week analysis (RIDAR study)
BACKGROUND: The objective was to analyze the effectiveness and safety of dual therapy with rilpivirine plus boosted-darunavir (RPV + bDRV) in real-life patients. METHODS: Observational, retrospective, multi-center study in HIV+ patients who had received RPV + bDRV for 24 weeks to optimize/simplify t...
Autores principales: | Pasquau, Juan, de Jesus, Samantha E., Arazo, Piedad, Crusells, María J., Ríos, María J., Lozano, Fernando, de la Torre, Javier, Galindo, María J., Carmena, Jorge, Santos, Jesús, Tornero, Carlos, Verdejo, Guillermo, Samperiz, Gloria, Palacios, Zaira, Hidalgo-Tenorio, Carmen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396540/ https://www.ncbi.nlm.nih.gov/pubmed/30819101 http://dx.doi.org/10.1186/s12879-019-3817-6 |
Ejemplares similares
-
Dual therapy with darunavir/r plus etravirine is safe and effective as switching therapy in antiretroviral experienced HIV-patients. The BITER Study
por: Portilla, Joaquín, et al.
Publicado: (2014) -
Safety and Efficacy of Dolutegravir Plus Rilpivirine in Treatment-Experienced HIV-Infected Patients: The DORIVIR Study
por: Palacios, Rosario, et al.
Publicado: (2018) -
Rildo: Real-World Multicenter Study on the Effectiveness and Safety of Single-Tablet Regimen of Dolutegravir plus Rilpivirine in Treatment-Experienced People Living with HIV
por: Hidalgo-Tenorio, Carmen, et al.
Publicado: (2022) -
Darunavir in experienced patients
por: Sterrantino, G, et al.
Publicado: (2010) -
Monotherapy with darunavir/ritonavir is effective and safe in clinical practice
por: Pasquau, Juan, et al.
Publicado: (2014)